AlzeCure Pharma AB (publ)
SSE:ALZCUR.ST
2.49 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.109 | 1.136 | 0.883 | 0 |
| Cost of Revenue
| 0.069 | 0.109 | 0.11 | 0.109 | 0.125 | 0.132 | 0.136 | 0.145 | 0.145 | 0.144 | 0.145 | 0.146 | 0.161 | 0.124 | 0 | 19.653 | 16.004 | 11.354 | 13.637 | 12.189 | 9.167 | 9.795 | 0 | 5.739 | 7.92 | 10.127 | 0 | 0 |
| Gross Profit
| -0.069 | -0.109 | -0.11 | -0.109 | -0.125 | -0.132 | -0.136 | -0.145 | -0.145 | -0.144 | -0.145 | -0.146 | -0.161 | -0.124 | 0 | -19.653 | -16.004 | -11.354 | -13.637 | -12.189 | -9.167 | -9.795 | 0 | -5.739 | -6.811 | -8.991 | 0.883 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.142 | -7.915 | 1 | 0 |
| Reseach & Development Expenses
| 5.788 | 7.012 | 6.946 | 5.628 | 7.898 | 7.125 | 8.199 | 8.934 | 18.888 | 10.162 | 19.674 | 14.174 | 13.334 | 19.533 | 15.315 | 19.653 | 16.004 | 11.354 | 13.637 | 12.189 | 9.167 | 9.795 | 13.146 | 5.739 | 7.92 | 10.127 | 6.205 | 0 |
| General & Administrative Expenses
| 2.997 | 2.935 | 2.983 | 2.334 | 2.579 | 2.702 | 2.834 | 2.191 | 2.618 | 2.525 | 2.893 | 2.37 | 2.621 | 3.381 | 2.498 | 1.88 | 2.587 | 2.388 | 2.054 | 1.156 | 1.129 | 1.697 | 30.753 | 0.456 | 0.715 | 0.571 | 0.402 | 0.328 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.768 | 4.675 |
| SG&A
| 2.997 | 2.935 | 2.983 | 2.334 | 2.579 | 2.702 | 2.834 | 2.191 | 2.618 | 2.525 | 2.893 | 2.37 | 2.621 | 3.381 | 2.498 | 1.88 | 2.587 | 2.388 | 2.054 | 1.156 | 1.129 | 1.697 | 30.753 | 0.456 | 0.715 | 0.571 | 0.402 | 5.003 |
| Other Expenses
| -0.088 | 0 | 0 | 0 | 0 | -0.065 | 0.124 | 0.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 8.785 | 9.998 | 9.929 | 7.969 | 10.497 | 9.762 | 11.157 | 11.172 | 21.574 | 12.666 | 22.866 | 16.542 | 15.731 | 23.004 | 18.21 | 21.503 | 18.458 | 13.851 | 15.782 | 13.426 | 10.307 | 11.49 | 13.123 | 5.67 | 7.722 | 9.624 | 5.668 | 5.003 |
| Operating Income
| -8.854 | -9.998 | -10.039 | -7.969 | -10.497 | -9.762 | -11.03 | -11.172 | -21.574 | -12.666 | -22.649 | -16.542 | -15.731 | -23.004 | -17.767 | -21.503 | -18.458 | -13.851 | -15.685 | -13.426 | -10.307 | -11.49 | -12.877 | -5.67 | -7.722 | -9.624 | -5.668 | -5.003 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.963 | -8.472 | -6.416 | 0 |
| Total Other Income Expenses Net
| 0.201 | 0 | 0.283 | 0.314 | 0.286 | 0.217 | 0.082 | 0.075 | 0.026 | 0.02 | 0.03 | 0.035 | 0.038 | 0.042 | 0.047 | 0.048 | 0.051 | 0.067 | 0.05 | 0.044 | 0.052 | -0.096 | -0.09 | 0 | -0.002 | 0 | -0.004 | -0.051 |
| Income Before Tax
| -8.653 | -9.804 | -9.756 | -7.655 | -10.211 | -9.545 | -10.948 | -11.097 | -21.548 | -12.646 | -22.619 | -16.507 | -15.693 | -22.962 | -17.72 | -21.455 | -18.407 | -13.784 | -15.635 | -13.382 | -10.255 | -11.586 | -12.967 | -5.67 | -7.724 | -9.624 | -5.672 | -5.054 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.965 | -8.472 | -6.421 | 0 |
| Income Tax Expense
| 0 | 0.001 | 0.066 | 0.315 | 0.292 | -0.217 | -0.082 | -0.075 | 0.029 | 0.021 | 0.03 | 0.035 | 0.039 | 0.042 | 0.047 | 0.048 | 0.051 | 0.068 | 0.061 | 0.063 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.051 |
| Net Income
| -8.653 | -9.804 | -9.756 | -7.655 | -10.211 | -9.328 | -10.866 | -11.022 | -21.548 | -12.646 | -22.619 | -16.507 | -15.693 | -22.962 | -17.72 | -21.455 | -18.407 | -13.784 | -15.635 | -13.382 | -10.255 | -11.586 | -12.967 | -5.67 | -7.724 | -9.624 | -5.672 | -5.054 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.965 | -8.472 | -6.421 | 0 |
| EPS
| -0.12 | -0.14 | -0.16 | -0.12 | -0.16 | -0.15 | -0.21 | -0.22 | -0.43 | -0.33 | -0.53 | -0.43 | -0.41 | -0.6 | -0.45 | -0.55 | -0.47 | -0.35 | -0.4 | -0.34 | -0.26 | -0.29 | -0.33 | -0.23 | -0.39 | -0.39 | -0.23 | -0.27 |
| EPS Diluted
| -0.12 | -0.14 | -0.16 | -0.12 | -0.16 | -0.15 | -0.21 | -0.22 | -0.42 | -0.32 | -0.51 | -0.43 | -0.41 | -0.6 | -0.45 | -0.54 | -0.47 | -0.35 | -0.4 | -0.34 | -0.26 | -0.29 | -0.33 | -0.23 | -0.39 | -0.39 | -0.23 | -0.27 |
| EBITDA
| -8.785 | -9.694 | -9.929 | -7.545 | -10.08 | -9.413 | -10.812 | -10.952 | -21.4 | -12.501 | -22.474 | -16.361 | -15.531 | -22.838 | -17.584 | -21.325 | -18.287 | -13.674 | -15.521 | -13.3 | -10.219 | -11.454 | -12.833 | -5.635 | -7.71 | -9.612 | -5.66 | -0.051 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.952 | -8.461 | -6.407 | 0 |